Katzenstein A-LA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157(4):1301–15.
Article CAS PubMed Google Scholar
King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378(9807):1949–61.
Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 2014;9(1):157–79.
Article CAS PubMed Google Scholar
Raghu G, Chen S-Y, Hou Q, Yeh W-S, Collard HR. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old. Eur Respir J. 2016;48(1):179–86.
Davis S, Rafia R, Carroll C, Hamilton J, Essat M. Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 2018.
Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med. 2018;378(19):1811–23.
Article CAS PubMed Google Scholar
Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, et al. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Respir J. 2016;47(1):243–53.
Article CAS PubMed PubMed Central Google Scholar
Wuyts WA, Kolb M, Stowasser S, Stansen W, Huggins JT, Raghu G. First Data on Efficacy and Safety of Nintedanib in patients with idiopathic pulmonary fibrosis and forced vital capacity of ≤ 50% of predicted value. Lung. 2016;194(5):739–43.
Article CAS PubMed PubMed Central Google Scholar
George PM, Patterson CM, Reed AK, Thillai M. Lung transplantation for idiopathic pulmonary fibrosis. Lancet Respiratory Med. 2019;7(3):271–82.
Riddell P, Kleinerova J, Eaton D, Healy DG, Javadpour H, McCarthy JF et al. Meaningful survival benefit for single lung transplantation in idiopathic pulmonary fibrosis patients over 65 years of age. Eur Respir J. 2020;56(1).
Pardo A, Selman M. Lung fibroblasts, aging, and idiopathic pulmonary fibrosis. Annals Am Thorac Soc. 2016;13(Supplement5):S417–21.
Glass DS, Grossfeld D, Renna HA, Agarwala P, Spiegler P, DeLeon J, et al. Idiopathic pulmonary fibrosis: current and future treatment. Clin Respir J. 2022;16(2):84–96.
Article PubMed PubMed Central Google Scholar
Wolters PJ, Blackwell TS, Eickelberg O, Loyd JE, Kaminski N, Jenkins G, et al. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? Lancet Respir Med. 2018;6(2):154–60.
Article PubMed PubMed Central Google Scholar
Parimon T, Yao C, Stripp BR, Noble PW, Chen P. Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis. Int J Mol Sci. 2020;21(7).
Sisson TH, Mendez M, Choi K, Subbotina N, Courey A, Cunningham A, et al. Targeted Injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med. 2010;181(3):254–63.
Article CAS PubMed Google Scholar
Armanios MY, Julian J-L, Chen PD, Joy D, Cogan PD, Jonathan K, Alder BA, Roxann G, Ingersoll BS, Cheryl Markin BS, Lawson WE, Xie MDM, Irma BS, Vulto BS, John A, Phillips MD III, Peter M, Lansdorp MD, Carol PD, Greider W, Ph.D., and, Loyd JE. M.D. Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis. 2007.
Alder JK, Barkauskas CE, Limjunyawong N, Stanley SE, Kembou F, Tuder RM, et al. Telomere dysfunction causes alveolar stem cell failure. Proc Natl Acad Sci U S A. 2015;112(16):5099–104.
Article CAS PubMed PubMed Central Google Scholar
Thomas AQ, Lane K, Phillips J, Prince M, Markin C, Speer M, et al. Heterozygosity for a Surfactant Protein C Gene Mutation Associated with Usual interstitial pneumonitis and Cellular nonspecific interstitial pneumonitis in one Kindred. Am J Respir Crit Care Med. 2002;165(9):1322–8.
Nureki S-I, Tomer Y, Venosa A, Katzen J, Russo SJ, Jamil S, et al. Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis. J Clin Invest. 2018;128(9):4008–24.
Article PubMed PubMed Central Google Scholar
Povedano JM, Martinez P, Flores JM, Mulero F, Blasco MA. Mice with pulmonary fibrosis driven by Telomere Dysfunction. Cell Rep. 2015;12(2):286–99.
Article CAS PubMed Google Scholar
Reyfman PA, Walter JM, Joshi N, Anekalla KR, McQuattie-Pimentel AC, Chiu S, et al. Single-cell transcriptomic analysis of human lung provides insights into the Pathobiology of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019;199(12):1517–36.
Article CAS PubMed PubMed Central Google Scholar
Adams TS, Schupp JC, Poli S, Ayaub EA, Neumark N, Ahangari F, et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv. 2020;6(28):eaba1983.
Article CAS PubMed PubMed Central Google Scholar
Habermann AC, Gutierrez AJ, Bui LT, Yahn SL, Winters NI, Calvi CL, et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci Adv. 2020;6(28):eaba1972.
Article CAS PubMed PubMed Central Google Scholar
Strunz M, Simon LM, Ansari M, Kathiriya JJ, Angelidis I, Mayr CH, et al. Alveolar regeneration through a Krt8 + transitional stem cell state that persists in human lung fibrosis. Nat Commun. 2020;11(1):3559.
Article CAS PubMed PubMed Central Google Scholar
Xu Y, Mizuno T, Sridharan A, Du Y, Guo M, Tang J et al. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI Insight. 2016;1(20).
Jiang P, Gil de Rubio R, Hrycaj SM, Gurczynski SJ, Riemondy KA, Moore BB, et al. Ineffectual type 2-to-type 1 alveolar epithelial cell differentiation in idiopathic pulmonary fibrosis: persistence of the KRT8(hi) transitional state. Am J Respir Crit Care Med. 2020;201(11):1443–7.
Article PubMed PubMed Central Google Scholar
Mayr CH, Simon LM, Leuschner G, Ansari M, Schniering J, Geyer PE et al. Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers. EMBO Mol Med. 2021;13(4).
Murthy KL, Preetish, Sontake V, Tata A, Kobayashi Y, Macadlo L, Okuda K, et al. Human distal lung maps and lineage hierarchies reveal a bipotent progenitor. Nature. 2022;604(7904):111–9.
Kathiriya JJ, Wang C, Zhou M, Brumwell A, Cassandras M, Le Saux CJ, et al. Human alveolar type 2 epithelium transdifferentiates into metaplastic KRT5(+) basal cells. Nat Cell Biol. 2022;24(1):10–23.
Article CAS PubMed Google Scholar
Enomoto Y, Katsura H, Fujimura T, Ogata A, Baba S, Yamaoka A, et al. Autocrine TGF-beta-positive feedback in profibrotic AT2-lineage cells plays a crucial role in non-inflammatory lung fibrogenesis. Nat Commun. 2023;14(1):4956.
Article CAS PubMed PubMed Central Google Scholar
Frank DB, Peng T, Zepp JA, Snitow M, Vincent TL, Penkala IJ, et al. Emergence of a Wave of wnt signaling that regulates Lung Alveologenesis by Controlling Epithelial Self-Renewal and differentiation. Cell Rep. 2016;17(9):2312–25.
Article CAS PubMed PubMed Central Google Scholar
Zepp JA, Zacharias WJ, Frank DB, Cavanaugh CA, Zhou S, Morley MP, et al. Distinct mesenchymal lineages and niches promote epithelial Self-Renewal and Myofibrogenesis in the lung. Cell. 2017;170(6):1134–e4810.
Article CAS PubMed PubMed Central Google Scholar
Aros CJ, Pantoja CJ, Gomperts BN. Wnt signaling in lung development, regeneration, and disease progression. Commun Biol. 2021;4(1):601.
Article PubMed PubMed Central Google Scholar
Barkauskas CE, Cronce MJ, Rackley CR, Bowie EJ, Keene DR, Stripp BR, et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest. 2013;123(7):3025–36.
Article CAS PubMed PubMed Central Google Scholar
Desai TJ, Brownfield DG, Krasnow MA. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature. 2014;507(7491):190–4.
Article CAS PubMed PubMed Central Google Scholar
Nabhan AN, Brownfield DG, Harbury PB, Krasnow MA, Desai TJ. Single-cell wnt signaling niches maintain stemness of alveolar type 2 cells. Science. 2018;359(6380):1118–23.
Article CAS PubMed PubMed Central Google Scholar
Zacharias WJ, Frank DB, Zepp JA, Morley MP, Alkhaleel FA, Kong J, et al. Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. Nature. 2018;555(7695):251–5.
Article CAS PubMed PubMed Central Google Scholar
Flozak AS, Lam AP, Russell S, Jain M, Peled ON, Sheppard KA, et al. Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells. J Biol Chem. 2010;285(5):3157–67.
Article CAS PubMed Google Scholar
Chilosi M, Poletti V, Zamò A, Lestani M, Montagna L, Piccoli P, et al. Aberrant Wnt/β-Catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol. 2003;162(5):1495–502.
Article CAS PubMed PubMed Central Google Scholar
Sucre JMS, Deutsch GH, Jetter CS, Ambalavanan N, Be
留言 (0)